EQNX — Equinox Nepremicnine dd Balance Sheet

0.000.00%

Last trade - 00:00

FinancialsBalancedSmall CapNeutral

Annual balance sheet for Equinox Nepremicnine dd, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	AAS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	—	10.8	3.65	0.353	0.151
Net Total Accounts Receivable
Net Total Receivables	—	0.909	2.72	4.26	3.91
Total Other Current Assets
Total Current Assets	—	11.7	6.38	6.24	4.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	2.65	0	0	0
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	—	60	53.3	51.4	55.9
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	—	6.21	1.36	1.44	2.25
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	—	18.8	13.4	13.5	16.4
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	—	41.3	39.8	37.9	39.5
Total Liabilities & Shareholders' Equity	—	60	53.3	51.4	55.9
Total Common Shares Outstanding